Search Results

Filter
  • 1-10 of  19,935 results for ""INTERFERON alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Construction of viral-based expression vectors for high-level production of human interferon alpha 2b in plants.

  • Authors : Sindarovska Y; Department of Genetic Engineering, Institute of Cell Biology and Genetic Engineering of NAS of Ukraine, Akad. Zabolotnogo Str., 148, Kyiv, 03148, Ukraine. .; Kuchuk M

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/metabolism ; Genetic Vectors*

  • Source: Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2024 Feb 23; Vol. 108 (1), pp. 229. Date of Electronic Publication: 2024 Feb 23.Publisher: Springer International Country of Publication: Germany NLM ID: 8406612 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotyping.

  • Authors : Woon ST; Molecular Immunology, LabPLUS, Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, New Zealand; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Electronic address: .

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Receptor, Interferon alpha-beta*/Receptor, Interferon alpha-beta*/Receptor, Interferon alpha-beta*/genetics; Humans

  • Source: Pathology [Pathology] 2024 Feb; Vol. 56 (1), pp. 92-97. Date of Electronic Publication: 2023 Oct 29.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV-1*/HIV-1*/HIV-1*/genetics ; Panobinostat*/Panobinostat*/Panobinostat*/therapeutic use

  • Source: Cell [Cell] 2024 Feb 29; Vol. 187 (5), pp. 1238-1254.e14. Date of Electronic Publication: 2024 Feb 17.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Progress in the clinical cure of the population of inactive hepatitis B surface antigen carriers].

  • Authors : Mo ZS; Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.; Gao ZL

Subjects: Hepatitis B Surface Antigens* ; Interferon-alpha*

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2023 Dec 20; Vol. 31 (12), pp. 1336-1339.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
Academic Journal

[Interferon-α mediating the functional damage of CD56 dim CD57 + natural killer cells in peripheral blood of systemic lupus erythematosuss].

  • Authors : Zhao XG; Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, Liaoning, China.; Liu JQ

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/metabolism ; Lupus Erythematosus, Systemic*

  • Source: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2023 Dec 18; Vol. 55 (6), pp. 975-981.Publisher: Beijing da xue Country of Publication: China NLM ID: 101125284 Publication Model: Print Cited Medium: Print ISSN: 1671-167X (Print)

Record details

×
Academic Journal

Engineering a New IFN-ApoA-I Fusion Protein with Low Toxicity and Prolonged Action.

  • Authors : Miroshnichenko S; Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Timakova str., 2, 630117 Novosibirsk, Russia.; Pykhtina M

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Apolipoproteins A*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2023 Dec 08; Vol. 28 (24). Date of Electronic Publication: 2023 Dec 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors.

  • Authors : Chowdhury S; Institute of Infection & Immunity, St George's, University of London, London, UK.; Latham KA

Subjects: Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/physiology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology; Humans

  • Source: The Journal of general virology [J Gen Virol] 2023 Dec; Vol. 104 (12).Publisher: Microbiology Society Country of Publication: England NLM ID: 0077340 Publication Model: Print Cited Medium: Internet ISSN: 1465-2099

Record details

×
Academic Journal

Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon-α response in BCR::ABL1 negative myeloproliferative neoplasms.

  • Authors : Ding L; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: Cancer science [Cancer Sci] 2023 Nov; Vol. 114 (11), pp. 4445-4458. Date of Electronic Publication: 2023 Sep 08.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
Academic Journal

RanBP2/Nup358 Mediates Sumoylation of STAT1 and Antagonizes Interferon-α-Mediated Antiviral Innate Immunity.

  • Authors : Li J; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China.; Su L

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Virus Diseases*; Humans

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 25; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

[A study of the clinical curative effect of nucleos(t)ide analogues treated to pegylated interferon-α add-on therapy in patients with chronic hepatitis B].

  • Authors : Liang H; Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.; Wang C

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use ; Polyethylene Glycols*/Polyethylene Glycols*/Polyethylene Glycols*/therapeutic use

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2023 Dec 20; Vol. 31 (12), pp. 1297-1305.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
  • 1-10 of  19,935 results for ""INTERFERON alpha""